GLP-1 medications alter gastrointestinal motility and can disrupt the gut microbiome
The butternut squash adds natural sweetness and complex carbohydrates
Several studies have shown to reduce the overall body fat percentage, belly fat and blood triglycerides
The earlier 12-week Phase 2a trial had shown encouraging results (2.6 kg vs 0.8 kg for placebo), but the larger, longer, better-powered trial reversed that finding
Potential Eye Health Risks While GLP-1 agonists have been heralded as life-changing for some individuals, recent studies and case reports suggest a connection between these drugs and certain eye health complications, particularly diabetic retinopathy and other forms of vision impairment
Evidence for dopamine D2 receptor mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies